Celldex Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 15K | 75K | 0 | 730K | 695K | 1.2M | 3.2M | 2.5M |
| Cost of Goods Sold | 854K | 0 | 62.9M | 54.2M | 52.6M | 819K | 45.3M | 797K |
| Gross Profit | -839K | 75K | -62.9M | -53.5M | -51.9M | 356K | -42.1M | 1.7M |
| R&D Expenses | 73.0M | 75.4M | 62.9M | 54.2M | 52.6M | 46.1M | 45.3M | 38.9M |
| Operating Expenses | 83.6M | 87.3M | 10.7M | 10.4M | 10.8M | 56.4M | 10.1M | 48.0M |
| Operating Income | -84.4M | -87.2M | -73.6M | -63.9M | -62.7M | -56.0M | -52.1M | -46.3M |
| Other Income / Gains | 5.8M | 5.8M | 6.6M | 7.3M | 8.9M | 8.9M | 10.0M | 10.5M |
| Net Income | -78.7M | -81.4M | -67.0M | -56.6M | -53.8M | -47.1M | -42.1M | -35.8M |
| EPS (Diluted) | -1.18 | -1.23 | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 | -0.54 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -55.933 | 1.00 | 0 | -73.241 | -74.704 | 0.303 | -13.185 | 0.681 |
| General And Administrative Expenses | 11.4M | 11.9M | 10.7M | 10.4M | 10.8M | 10.3M | 10.1M | 9.1M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 11.4M | 11.9M | 10.7M | 10.4M | 10.8M | 10.3M | 10.1M | 9.1M |
| Other Expenses | -854K | 0 | -62.9M | -54.2M | -52.6M | 0 | -45.3M | 0 |
| Cost And Expenses | 84.5M | 87.3M | 73.6M | 64.6M | 63.4M | 57.2M | 55.3M | 48.8M |
| Interest Income | 5.8M | 5.8M | 6.6M | 7.3M | 8.9M | 8.9M | 10.0M | 10.5M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 854K | 816K | 824K | 873K | 867K | 819K | 786K | 797K |
| Ebitda | -77.8M | -80.5M | -66.2M | -55.7M | -52.9M | -46.3M | -41.3M | -35.0M |
| Ebitdaratio | -5K | -1K | 0 | -76.338 | -76.157 | -39.381 | -12.954 | -14.029 |
| Operating Income Ratio | -6K | -1K | 0 | -87.475 | -90.272 | -47.683 | -16.335 | -18.542 |
| Income Before Tax | -78.7M | -81.4M | -67.0M | -56.6M | -53.8M | -47.1M | -42.1M | -35.8M |
| Income Before Tax Ratio | -5K | -1K | 0 | -77.534 | -77.404 | -40.078 | -13.20 | -14.348 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -5K | -1K | 0 | -77.534 | -77.404 | -40.078 | -13.20 | -14.348 |
| Epsdiluted | -1.18 | -1.23 | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 | -0.54 |
| Weighted Average Shs Out | 66.6M | 66.5M | 66.4M | 66.4M | 66.4M | 66.4M | 66.3M | 66.0M |
| Weighted Average Shs Out Dil | 66.6M | 66.5M | 66.4M | 66.4M | 66.4M | 66.4M | 66.3M | 66.0M |